Old Web
English
Sign In
Acemap
>
Paper
>
The use of Imatinib mesylate (Glivec) in Nigerian patients with chronic myeloid leukemia.
The use of Imatinib mesylate (Glivec) in Nigerian patients with chronic myeloid leukemia.
2008
Durosinmi Ma
Julius Olaoye Faluyi
Anthony Oyekunle
Lateef Salawu
I. A. Adediran
Akinola No
O. O. Bamgbade
Okanny Cc
S Akanmu
Ogbe Op
Tamunomieibi Wakama
C.A Nwauche
M. E. Enosolease
D. N. K. Halim
G. N. Bazuaye
Chide Okocha
J. A. Olaniyi
T. S. Akingbola
V. O. Mabayoje
A.A Raji
Ai Mamman
A. Kuliya-Gwarzo
Obike Ibegbulam
Sunday Ocheni
Y Tanko
O. P. Arewa
Rahman Bolarinwa
D. O. Kassim
Ndakotsu Ma
O. A. Amusu
Olufemi O Akinyanju
Keywords:
Mesylate
Cancer research
Myeloid leukemia
Imatinib
Medicine
imatinib mesylate
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
4
Citations
NaN
KQI
[]